Particle.news
Download on the App Store

Mexican Experts Say 8 Million Live With Rare Diseases, Urge National Registry

The push centers on shortening years-long diagnostic odysseys through expanded genomic testing with better access to therapies.

Overview

  • At an AMIIF press conference in Morelia, IMSS geneticist Haydée Rosas Vargas and pediatrician Leticia Belmont called for a secure, dynamic national registry to guide care and policy.
  • Specialists estimate around 8 million people in Mexico have one of 7,000–8,000 rare conditions, aligning with roughly 300 million affected globally.
  • About 70–72% of rare diseases are genetic and often begin in childhood, with up to 30% of affected children dying before age five due to late or incorrect diagnosis.
  • Patients can spend 5–30 years seeking a diagnosis after seeing 4–12 specialists, with 40% misdiagnosed and many traveling far for answers or missing genetic counseling.
  • Fewer than 5% of rare diseases have specific treatments; of 689 orphan drugs worldwide, 96 had Mexican authorization by February 2024, prompting calls for expanded newborn screening (up to 75 conditions), broader genomic sequencing capacity and designated reference centers.